Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis

Ha Il Kim, Jihyun An, Seungbong Han, Ju Hyun Shim

Clin Mol Hepatol. 2023;29(4):1013-1028. Published online July 5, 2023

DOI: https://doi.org/10.3350/cmh.2023.0131

View: 1508 Download: 94 Citation: 1

Letter to the Editor

Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Jihyun An, Ju Hyun Shim

Clin Mol Hepatol. 2022;28(2):267-268. Published online January 18, 2022

DOI: https://doi.org/10.3350/cmh.2022.0013

View: 2386 Download: 49

Original Article

Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Jihyun An, Hyung-Don Kim, Seon-Ok Kim, Ha Il Kim, Gi-Won Song, Han Chu Lee, Ju Hyun Shim

Clin Mol Hepatol. 2022;28(1):67-76. Published online October 12, 2021

DOI: https://doi.org/10.3350/cmh.2021.0202

View: 4100 Download: 169 Citations: 2

Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial

Sang Min Yoon, So Yeon Kim, Young-Suk Lim, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Jihyun An, Jinhong Jung, Jong Hoon Kim, Han Chu Lee

Clin Mol Hepatol. 2020;26(4):506-515. Published online July 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0038

View: 5448 Download: 189 Citations: 42

Editorial

Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?

Ju Hyun Shim

Clin Mol Hepatol. 2020;26(2):183-184. Published online March 12, 2020

DOI: https://doi.org/10.3350/cmh.2020.0042

View: 3812 Download: 104 Citations: 6

Original Article

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion

Danbi Lee, Han Chu Lee, Jihyun An, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2018;24(2):144-150. Published online January 16, 2018

DOI: https://doi.org/10.3350/cmh.2017.0041

View: 8539 Download: 170 Citations: 11

Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion

Jihyun An, Kwang Sun Lee, Kang Mo Kim, Do Hyun Park, Sang Soo Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2017;23(2):160-169. Published online May 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0088

View: 8157 Download: 232 Citations: 25

Liver Imaging

Focal type of peliosis hepatis

Gil-Sun Hong, Kyoung Won Kim, Jihyun An, Ju Hyun Shim, Jihun Kim, Eun Sil Yu

Clin Mol Hepatol. 2015;21(4):398-401. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.398

View: 7760 Download: 105 Citations: 6

Case Report

A case of primary hepatic actinomycosis: an enigmatic inflammatory lesion of the liver

Yeon Jung Ha, Ji Hyun An, Ju Hyun Shim, Eun Sil Yu, Jong Jae Kim, Tae Yong Ha, Han Chu Lee

Clin Mol Hepatol. 2015;21(1):80-84. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.80

View: 7438 Download: 102 Citations: 7

Original Article

Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma

Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eun Sil Yu, Ki Hun Kim, Seung-Mi Kim, Tae Won Kim, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2015;21(1):60-70. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.60

View: 7972 Download: 125 Citations: 20

No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients

Nae-Yun Heo, Young-Suk Lim, Woochang Lee, Minkyung Oh, Jiyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee, Dong Jin Suh

Clin Mol Hepatol. 2014;20(2):177-184. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.177

View: 6490 Download: 57 Citations: 4

Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma

Jee Eun Yang, Eunji Park, Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eunsil Yu, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2014;20(1):28-37. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.28

View: 7199 Download: 62 Citations: 2

Case Report

Drug rash with eosinophilia and systemic symptoms syndrome following cholestatic hepatitis A: a case report

Jihyun An, Joo Ho Lee, Hyojeong Lee, Eunsil Yu, Dan Bi Lee, Ju Hyun Shim, Sunyoung Yoon, Yumi Lee, Soeun Park, Han Chu Lee

Clin Mol Hepatol. 2012;18(1):84-88. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.84

View: 6285 Download: 53 Citations: 8

Original Article

Treatment and clinical outcome of needle-track seeding from hepatocellular carcinoma

Dong-Won Ahn, Ju Hyun Shim, Jung-Hwan Yoon, Chung Yong Kim, Hyo-Suk Lee, Yeong Tae Kim, Yoon Jun Kim

Clin Mol Hepatol. 2011;17(2):106-112. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.106

View: 6436 Download: 48 Citations: 16

Cardiovascular Risk in Chronic Hepatitis B Patients Treated with Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide

Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi

Received August 25, 2023 Accepted November 19, 2023

DOI: https://doi.org/10.3350/cmh.2023.0328 [Accepted]

View: 220 Download: 29

1 |

Viewed By 4724	Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Viewed By 4720	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3715	MAFLD: How is it different from NAFLD?
Viewed By 2593	Management of refractory ascites
Viewed By 2421	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 128	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 77	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 57	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 55	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 54	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Search